文献速递泌尿生殖MR

PI-RADS 2.1版:前列腺MRI的一小步

PI-RADS version 2.1: one small step for prostate MRI.
PubMed 文献 · Clin Radiol · 2019-06-22

多参数前列腺MRI在疑似前列腺癌诊断中作用日益突出,活检前mpMRI可避免部分活检并对可疑病灶靶向穿刺。PI-RADS v2广泛使用后暴露出观察者间变异等问题,尤其移行区评估,v2.1针对这些局限提出关键修改,本文阐述其背景依据与证据。

要点

  • PI-RADS v2.1针对移行区评估的观察者间变异等局限进行了修订。
  • 高质量图像采集、解读和报告沟通是mpMRI技术成功的关键。
  • 活检前mpMRI在特定临床情况下可避免活检并对可疑病灶靶向穿刺。

核心结论

  • PI-RADS v2.1针对v2版广泛使用后暴露的不一致性和局限性提出关键修改,尤其涉及移行区评估的观察者间变异。

研究设计与样本

  • 本文为综述,阐述PI-RADS v2.1的关键修改及其背景理由与证据,未报告检索范围与纳入文献数量。

诊断标准与关键数值

  • PI-RADS v2.1针对v2版在移行区评估观察者间变异等方面的局限性提出修改,原文未报告具体诊断标准数值。

临床应用与阅片要点

  • 活检前mpMRI在特定临床情况下可避免活检,并对可疑病灶靶向穿刺以助正确诊断。
  • mpMRI的成功高度依赖高质量图像采集、解读和报告沟通。

局限性

  • PI-RADS v2广泛采用后暴露出不一致性和局限性,尤其移行区评估的观察者间变异。
  • 原文未报告本文作为综述的检索范围与纳入文献数量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Multiparametric (mp) prostate magnetic resonance imaging (MRI) is playing an increasingly prominent role in the diagnostic work-up of patients with suspected prostate cancer. Performing mpMRI before biopsy offers several advantages including biopsy avoidance under certain clinical circumstances and targeting biopsy of suspicious lesions to enable the correct diagnosis. The success of the technique is heavily dependent on high-quality image acquisition, interpretation, and report communication, all areas addressed by previous versions of the Prostate Imaging-Reporting and Data System (PI-RADS) recommendations. Numerous studies have validated the approach, but the widespread adoption of PI-RADS version 2 has also highlighted inconsistencies and limitations, particularly relating to interobserver variability for evaluation of the transition zone. These limitations are addressed in the recently released version 2.1. In this article, we highlight the key changes proposed in PI-RADS v2.1 and explore the background reasoning and evidence for the recommendations.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Barrett T, Rajesh A, Rosenkrantz AB, et al. PI-RADS version 2.1: one small step for prostate MRI. Clin Radiol. 2019. PMID: 31239107. doi:10.1016/j.crad.2019.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。